4. Antagonists Flashcards

1
Q

Steps of antagonist to effect

A
  • receptor
  • antagonist-receptor complex
  • effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain steps of propranolol to effect

A
  • on beta-adrenoreceptor
  • propranolol-beta-adrenoreceptor complex
  • decreased blood pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 classes of antagonist

A
  • chemical
  • physiological
  • pharmacological
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain ‘chemical antagonists’

A
  • binding of two agents to render active drug inactive
  • commonly called chelating agents
  • example is protamine binds/sequesters heparin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain physiological antagonists

A
  • two agents with opposite effects cancelling each other out
  • e.g glucocorticoids and insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain pharmacological antagonists

A
  • binds to receptor
  • blocks normal action of agonist on receptor responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antagonists can be receptor or non-receptor. 2 types of non-receptor antagonists are …

A
  • chemical
  • physiological
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain how non-receptor antagonists work

A
  • doesn’t bind to same receptor as agonist but inhibits ability of agonist to initiate response
  • this occurs by inhibiting agonist directly by inhibiting a downstream molecule in activation pathway or activating pathway that opposes agonist
  • chemical ones inactivate agonist before it’s opportunity to act e.g chem neutralisation
  • physiological ones cause physiological effect opposite to that induced by agonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Receptor antagonists can have … binding or … binding and both of these can be … or …

A
  • allosteric
  • active site
  • reversible or irreversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A reversible active site binding antagonist is …
What happens here?

A
  • competitive
  • action of agonist will come back when antagonist is lost
  • adding more agonist gives it more chance of binding and vice versa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Reversible and irreversible allosteric binding antagonists are non-comp/comp?

A

non-comp
(all are non-comp except reversible active site binding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pure antagonists alone have what effect when binding to receptor?

A

no action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kind of efficacy do antagonists have?

A

none
AR* for antagonists doesn’t exist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do competitive active site antagonists work?

A
  • binds and prevents agonist action but can be overcome with increased agonist conc
  • causes parallel shift to right of agonist-response curve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do non-competitive active site antagonists work?

A
  • binds and form irreversible covalent bonds with receptor
  • causes parallel shift right of agonist-response curve AND reduced maximal asymptote
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do non-competitive allosteric antagonists work?

A
  • signal transduction rather than receptor effects
  • downstream responses are blocked e.g calcium ion influx
  • reduces slope and maximum of dose response curve
17
Q

How does an agonist curve look with a competitive antagonist?
Why?

A
  • same form but displaced to the right
  • same maximal response
  • linear portion of curves are parallel
  • because comp antagonist binds reversibly with receptor, gives rise to antagonism which can be overcome by increased conc of agonist
18
Q

Equation for dose ratio

A

agonist +antagonist EC50 (x)/agonist EC50 (y)

19
Q

What is the Schild equation?

A

r-1 = [B]/Kb

r is dose ratio
B is antagonist conc
Kb - antagonist dissocation constant

20
Q

What do pA2 values describe?
When does it work?

A

the activity of a receptor antagonist in simple numbers
pA2 = -logKb
- only works if relationship is linear and slope of Schild plot is 1/a comp antagonist

21
Q

Implications of comp antagonists on clinic

A
  • extent of agonist inhibition depends on conc of competing antagonist (varies in response to normal physical activity as well as disease states)
  • extent of inhibition depends on antagonist’s conc (inter individual diffs in metabolism or clearance influence plasma concs)
22
Q

How does the agonist curve look with an irreversible antagonist?
Why?

A
  • don’t have same form and reduced maximal response
  • ant binds irreversibly to receptor and gives rise to antagonism which cannot be overcome by increased conc of agonist
23
Q

Irreversible antagonism on a concentration response graph

A
  • increased EC50
  • duration of effect related to receptor turnover
  • receptor reserves allow parallel shift to right
24
Q

Weak partial agonists are also …

A

irreversible antagonists

25
Q

Which is most common? Competitive or irreversible antagonism?

A

competitive

26
Q

Examples of competitive antagonists

A
  • cimetidine at H2 receptor
  • tamoxifen at oestrogen receptor
27
Q

Examples of irreversible antagonists

A

phenoxybenzamine at alpha1 adrenoreceptor

28
Q

Why are reversible inhibitors advantageous?

A
  • once inhibited, receptor has to be regenerated
  • extreme situations can be avoided
  • receptor exists for a reason in the first place and don’t want to remove function completely
29
Q

How does a non-comp antagonist work?

A
  • blocks signal transduction events
  • inhibit agonist action by stopping something that signals outside
  • no physical blockage
  • reduces slope and maximal effect
  • e.g nifedipine blocks calcium ion influc
30
Q

Define ‘therapeutic window/index’

A

proportion of unwanted effects of all effects like sickness or headache

31
Q

Equation for risk:benefit ratio

A

TD50/ED50
or
LD50/ED50

32
Q

What does it mean to have a small or large therapeutic window?

A
  • large means concentration we need to give desired effect is much lower than conc where we see unwanted effects
  • small means the gap is smaller and it’s easier to get side effects
33
Q

Example of drug with small or large TI

A

small is warfarin
large is penicillin